Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 6:37 PM
Ignite Modification Date:
2025-12-24 @ 6:37 PM
NCT ID:
NCT00223457
Eligibility Criteria:
Inclusion Criteria:
* Diagnosis of relapsing form of multiple sclerosis
* Age 18 or older
* Therapy with disease modifying agent (Glatiramer acetate, Interferon Beta-1b, ot Interferon Beta 1a (IM or SC) for at least 6 months
* Access to the internet to complete the study survey
Exclusion Criteria:
* Diagnosis of progressive forms of multiple sclerosis
* Therapy on DMA for less than 6 months
* Inability to complete the survey
* Participation in other investigational studies within the last 6 months
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT00223457
Study Brief:
Protocol Section:
NCT00223457